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An Overview of Phthalate Ester
Carcinogenicity Testing Results.
The Past
by J. Wilbourn* and R. Montesano*
This paper presents a short review of the available carcinogenicity tests which have been
carried out on various phthalate esters prior to the availability ofthe National Cancer Institute
bioassay studies. All ofthese studies suffer from diverse limitations in design or reporting when
compared to more recent experimental protocols and reports.
There are three papers related to di(2-ethylhexyl) phthalate, one to di-n-butyl phthalate, two to
butyl benzyl phthalate, one to ethyl phthalyl ethyl glycolate and another to butyl phthalylbutyl
glycolate (1).
Di(2-ethylhexyl) Phthalate (DEHP)
The first experiment was carried out in 1953 in
Sherman rats. Groups of32 male and 32 female rats
were administered 0.04, 0.13 or 0.4% DEHP in the
diet for a maximum of two years. The doses were
equivalentto0. 20, 60and200mg/kgbodyweight/day,
respectively. Controls(numberunspecified)received
basal diet alone. After one year, 42% ofthe control
rats and the same percentage ofrats at the highest
dose level survived. The various groups were
reduced to a maximum of eight males and eight
females per group at the end of one year. Two
groups of 32 males and 32 females (F1 progeny)
were generated from the control and high dose P
generation and at 15days ofage weremaintained at
a dose level of0.4% DEHP in the diet for one year,
atwhich time the animals were killed. Some tumors
were observed in the animals surviving longer than
a year, but they were equally scattered among the
different groups, so that, on the basis of this
experiment, it was not possible to conclude either a
negative or positive carcinogenic response to this
chemical (2). The small number of animals, poor
survivalandlimitedreportingmakethisexperiment
inadequate in terms of a carcinogenicity bioassay.
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The second experiment was carried outby Harris
et al. (3) on Wistar rats. Groups of43 males and 43
femalerats were fed DEHP at adose of0, 0.1% and
0.5% in the diet for a maximum oftwo years, which
corresponded to an intake of about 0, 70 and 250
mg/kg body weight/day, respectively. In this ex-
periment, groups of animals were sacrificed at
various times, namely, at 3, 6, 12, and 24 months,
the number of animals sacrificed being four, four,
10and24rats,respectively. Pathologicalexamination,
however, wasnotcarriedoutforallanimalssacrificed,
but only in eight males and eight females per group
at 12 months, and in one to a maximum offour rats
in the treated and control groups at two years. No
tumors were observed. In addition to the limited
pathology examination carried out, this study has
the same limitations as the previous experiment in
regard to the possibility of assessing the car-
cinogenicity of this chemical.
An experiment in 1974 by Onda et al. cited by
Omori (4) which was originally reported as an
abstract in Japanese, mentions the induction of
renal cysts in the F1 and F2 generations of ddY or
ICR mice treated& with 10 or 100 mg/kg body
weight/dayDEHP, butitisnotclearifthetreatment
of the animals was carried out only in the parent
generation, orifit was continued alsointoF1 and F2
generations. Thisexperimentcouldnotbeevaluated
for carcinogenicity.128 WILBOURN AND MONTESANO
Di-n-butyl Phthalate
A similar experiment cited by Omori (4) on
di-n-butyl phthalate reported less severe effects on
the kidney; this study also cannot be used for an
evaluation of carcinogenicity.
Butyl Benzyl Phthalate
An experiment was carried out on butyl benzyl
phthalate by Theiss et al. (5) on male strain A/St
mice aged 6-8 weeks, in which mice were given IP
injections of 160, 400 or 800 mg/kg body weight
three times/week for 8 weeks. The animals were
killed at 24 weeks and examined for the number of
lungtumorsdetectedmacroscopically. Thenumbers
of lung tumors per mouse were 0.1-0.25 in treated
groups, compared with 0.39 in the corresponding
vehicle controls. A negative effect in this test
system cannot be taken as evidence for the absence
of a carcinogenic effect.
Butyl benzyl phthalate was administered to a
group of20 male and 20femaleWistarrats at adose
of5 mg/kgbody weight/day (exact route and length
oftreatment unspecified). There was 100% survival
at two years. Nontumorous pathological changes
were reported to occur in the kidney as well as
atrophy ofthe testes, but no tumors were observed.
No details were given concerning control rats,
whichmakesthisexperiment(6)difficulttoevaluate.
Ethyl Phthalylethyl Glycolate
Ethyl phthalylethyl glycolate was administered
to Wistar rats at doses of 0.05, 0.5 and 5% in the
diet for a period of two years. No difference in
survival occurred between the two lowest dose
groups and the controls (exact survival times not
reported), whereas none of the animals in the 5%
dose group survived longer than 72 weeks. In this
experiment, no tumors were observed, but some
kidney pathology was observed in the highest dose
group (7). The lack ofdetails on survival makes this
experiment impossible to evaluate.
Butyl Phthalylbutyl Glycolate
Butyl phthalylbutyl glycolate was administered
to groups of 20 Sherman rats (sex unspecified) at
three dose levels (200, 2000 and 20,000 mg/kg body
weight) in the diet for two years. A group of 40
controlsreceivedthebasaldiet. Althoughnotumors
were reported to occur, more than 80 rats were
killed before the end ofthe observation period, and
it is difficult to assess the number of animals
surviving or at risk to develop tumors (8).
In conclusion, these various experiments do not
allow any evaluation ofthe carcinogenicity ofthese
chemicals in mice or rats.
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